Stay updated on INTRUST: Urelumab/Nivolumab Combo Clinical Trial
Sign up to get notified when there's something new on the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page.

Latest updates to the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the full study record with a minimal message. As a result, core trial details and history sections are no longer visible, blocking access to the study information.SummaryDifference20%

- Check36 days agoChange DetectedThe page now shows revision v3.6.6, replacing the earlier v3.6.5 revision, signaling a minor update to the document version.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision: v3.6.5 has been added to the page, replacing the previous v3.6.4, indicating a new page revision without visible data changes.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page version was updated to v3.6.4, signaling a new release of the page's underlying framework. This update does not modify the study details or other user-facing information.SummaryDifference0.0%

- Check94 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, representing a minor update to the page's documentation/version, with no change to study details or content.SummaryDifference0.0%

- Check101 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a newer revision of the page. This is a metadata update and does not change core study content or user-facing information.SummaryDifference0.0%

Stay in the know with updates to INTRUST: Urelumab/Nivolumab Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page.